跳至主要内容
临床试验/NCT01012648
NCT01012648Unknown4 期

Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury

University of Zurich1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2009年11月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
48
试验地点
1
主要终点
Reduced amount of fluids given

研究概览

简要总结

RCT colloids versus cristalloids only in severe burn victims.

  • Trial with medicinal product

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Deep burn injury more than 15% of total body surface area (2nd and 3rd degree burns)
  • •Informed consent (via deferred consent, if necessary, according to Swiss HMG § 55 and 56).
  • •Patients or relatives can understand the study information and the provided information in German language

排除标准

  • •Patients expected to succumb within the next 24 to 36 hours, i.e. whole body burn trauma, palliative care situation
  • •Pregnancy
  • •No informed consent
  • •Known allergic reaction to HES
  • •Patients or patient's relatives, who do not understand the German language and therefore the study information, can not be provided in a legally correct manner.
  • •Patients with contraindications for balanced 6% HES 130/0.4, i.e. heart failure, pulmonary edema, intracerebral bleeding, acute renal failure, severe hypernatraemia and other severe electrolyte imbalances, severe von-Willebrand Syndrome and acute liver failure (see "Arzneimittelkompendium der Schweiz® - Documed")

结局指标

主要结局

Reduced amount of fluids given

时间窗: 3 days

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验